FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Moshe Laudon

Research Profile

Chemicals & Drugs

Living Beings

Concepts & Ideas

Physiology

Sleep

Disorders

Sleep Initiation and Maintenance Disorders

Procedures

Anatomy

Devices

Placebos

Co-author Network

Publications

TOP 3
Ehud Grossman; Moshe Laudon; Nava Zisapel
Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials.
Doron Garfinkel; Moshe Laudon; Zipora Matas; Julio Wainstein; Mariana Zorin; Nava Zisapel
Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study.
Patrick Lemoine; Tali Nir; Doron Garfinkel; Moshe Laudon; Nava Zisapel
Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Moshe Laudon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Ehud Grossman; Moshe Laudon; Nava Zisapel
Effect of melatonin on nocturnal blood pressure: meta-analysis of randomized controlled trials.
Vascular health and risk management 2011;7():577-84.
2011: Doron Garfinkel; Moshe Laudon; Zipora Matas; Julio Wainstein; Mariana Zorin; Nava Zisapel
Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study.
Diabetes, metabolic syndrome and obesity : targets and therapy 2011;4():307-13.
2011: Patrick Lemoine; Tali Nir; Doron Garfinkel; Moshe Laudon; Nava Zisapel
Prolonged-release melatonin for insomnia - an open-label long-term study of efficacy, safety, and withdrawal.
Therapeutics and clinical risk management 2011;7():301-11.
2011: Alan G Wade; Gordon Crawford; Ian Ford; Alex McConnachie; Tali Nir; Moshe Laudon; Nava Zisapel
Prolonged release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response.
Current medical research and opinion 2011;27(1):87-98.
2010: Alan G Wade; Ian Ford; Gordon Crawford; Alex McConnachie; Tali Nir; Moshe Laudon; Nava Zisapel
Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
BMC medicine 2010;8():51.
2007: Patrick Lemoine; Tali Nir; Moshe Laudon; Nava Zisapel
Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects.
Journal of sleep research 2007;16(4):372-80.
2007: Alan G Wade; Ian Ford; Gordon Crawford; Alex D McMahon; Tali Nir; Moshe Laudon; Nava Zisapel
Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes.
Current medical research and opinion 2007;23(10):2597-605.
2006: Ehud Grossman; Moshe Laudon; Ridvan Yalcin; Hakan Zengil; Edna Peleg; Yehonatan Sharabi; Yehuda Kamari; Zila Shen-Orr; Nava Zisapel
Melatonin reduces night blood pressure in patients with nocturnal hypertension.
The American journal of medicine 2006;119(10):898-902.
2004: Damien Leger; Moshe Laudon; Nava Zisapel
Nocturnal 6-sulfatoxymelatonin excretion in insomnia and its relation to the response to melatonin replacement therapy.
The American journal of medicine 2004;116(2):91-5.
2003: Ricardo Tarrasch; Moshe Laudon; Nava Zisapel
Cross-cultural validation of the Leeds sleep evaluation questionnaire (LSEQ) in insomnia patients.
Human psychopharmacology 2003;18(8):603-10.
2003: Sami Leppämäki; Timo Partonen; Olli Vakkuri; Jouko Lönnqvist; Markku Partinen; Moshe Laudon
Effect of controlled-release melatonin on sleep quality, mood, and quality of life in subjects with seasonal or weather-associated changes in mood and behaviour.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 2003;13(3):137-45.
2003: Michael Jonas; Doron Garfinkel; Nava Zisapel; Moshe Laudon; Ehud Grossman
Impaired nocturnal melatonin secretion in non-dipper hypertensive patients.
Blood pressure 2003;12(1):19-24.
2003: Nava Zisapel; Moshe Laudon
Subjective assessment of the effects of CNS-active drugs on sleep by the Leeds sleep evaluation questionnaire: a review.
Human psychopharmacology 2003;18(1):1-20.
2002: Sari Goldstein Ferber; Moshe Laudon; Jacob Kuint; Aron Weller; Nava Zisapel
Massage therapy by mothers enhances the adjustment of circadian rhythms to the nocturnal period in full-term infants.
Journal of developmental and behavioral pediatrics : JDBP 2002;23(6):410-5.
2002: Paolo Lissoni; Fabio Malugani; Ola Malysheva; Vladimir Kozlov; Moshe Laudon; Ario Conti; Georges Maestroni
Neuroimmunotherapy of untreatable metastatic solid tumors with subcutaneous low-dose interleukin-2, melatonin and naltrexone: modulation of interleukin-2-induced antitumor immunity by blocking the opioid system.
Neuro endocrinology letters 2002;23(4):341-4.
2002: Riva Tauman; Nava Zisapel; Moshe Laudon; Haim Nehama; Yakov Sivan
Melatonin production in infants.
Pediatric neurology 2002;26(5):379-82.
2002: Yichayaou Beloosesky; Joseph Grinblat; Moshe Laudon; Boris Grosman; Jonathan Y Streifler; Nava Zisapel
Melatonin rhythms in stroke patients.
Neuroscience letters 2002;319(2):103-6.
2001: Eyal Shamir; Yoram Barak; I Shalman; Moshe Laudon; Nava Zisapel; Ricardo Tarrasch; Avner Elizur; Ronit Weizman
Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study.
Archives of general psychiatry 2001;58(11):1049-52.
2001: Paolo Lissoni; P Cangemi; D Pirato; maria grazia roselli; Franco Rovelli; Fernando Brivio; Fabio Malugani; Georges Maestroni; Ario Conti; Moshe Laudon; O Malysheva; Luisa Giani
A review on cancer--psychospiritual status interactions.
Neuro endocrinology letters 2001;22(3):175-80.
2001: Yakov Sivan; Moshe Laudon; Riva Tauman; Nava Zisapel
Melatonin production in healthy infants: evidence for seasonal variations.
Pediatric research 2001;49(1):63-8.
2000: Eyal Shamir; Vadim S Rotenberg; Moshe Laudon; Nava Zisapel; Avner Elizur
First-night effect of melatonin treatment in patients with chronic schizophrenia.
Journal of clinical psychopharmacology 2000;20(6):691-4.
2000: James E Jan; D Hamilton; N Seward; Diane K Fast; Roger D Freeman; Moshe Laudon
Clinical trials of controlled-release melatonin in children with sleep-wake cycle disorders.
Journal of pineal research 2000;29(1):34-9.
2000: Yakov Sivan; Moshe Laudon; Jacob Kuint; Nava Zisapel
Low melatonin production in infants with a life-threatening event.
Developmental medicine and child neurology 2000;42(7):487-91.
2000: Eyal Shamir; Moshe Laudon; Yoram Barak; Yosef Anis; Vadim S Rotenberg; Avner Elizur; Nava Zisapel
Melatonin improves sleep quality of patients with chronic schizophrenia.
The Journal of clinical psychiatry 2000;61(5):373-7.
1999: Doron Garfinkel; Nava Zisapel; J Wainstein; Moshe Laudon
Facilitation of benzodiazepine discontinuation by melatonin: a new clinical approach.
Archives of internal medicine 1999;159(20):2456-60.
1999: James E Jan; M B Connolly; D Hamilton; Roger D Freeman; Moshe Laudon
Melatonin treatment of non-epileptic myoclonus in children.
Developmental medicine and child neurology 1999;41(4):255-9.
1999: Paolo Lissoni; Franco Rovelli; S Pittalis; M Casati; Luisa Giani; S Barni; Luca Fumagalli; Moshe Laudon
[Therapy with melatonin does not suppress its endogenous production in healthy volunteers].
Recenti progressi in medicina 1999;90(2):84-5.
1998: Eli Gilad; Moshe Laudon; Haim Matzkin; Nava Zisapel
Evidence for a local action of melatonin on the rat prostate.
The Journal of urology 1998;159(3):1069-73.
1997: Yaron Dagan; Nava Zisapel; D Nof; Moshe Laudon; J Atsmon
Rapid reversal of tolerance to benzodiazepine hypnotics by treatment with oral melatonin: a case report.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1997;7(2):157-60.
1997: Doron Garfinkel; Moshe Laudon; Nava Zisapel
Improvement of sleep quality by controlled-release melatonin in benzodiazepine-treated elderly insomniacs.
Archives of gerontology and geriatrics 1997;24(2):223-31.
1996: Moshe Laudon; Eli Gilad; Haim Matzkin; Z Braf; Nava Zisapel
Putative melatonin receptors in benign human prostate tissue.
The Journal of clinical endocrinology and metabolism 1996;81(4):1336-42.
1996: Eli Gilad; Moshe Laudon; Haim Matzkin; Edgar Pick; Mario Sofer; Z Braf; Nava Zisapel
Functional melatonin receptors in human prostate epithelial cells.
Endocrinology 1996;137(4):1412-7.
1996: J Atsmon; Sol Oaknin; Moshe Laudon; S Laschiner; Moshe Gavish; Yaron Dagan; Nava Zisapel
Reciprocal effects of chronic diazepam and melatonin on brain melatonin and benzodiazepine binding sites.
Journal of pineal research 1996;20(2):65-71.
1995: I Haimov; Peretz Lavie; Moshe Laudon; Paula Herer; C Vigder; Nava Zisapel
Melatonin replacement therapy of elderly insomniacs.
Sleep 1995;18(7):598-603.
1995: Doron Garfinkel; Moshe Laudon; D Nof; Nava Zisapel
Improvement of sleep quality in elderly people by controlled-release melatonin.
Lancet 1995;346(8974):541-4.
1994: I Haimov; Moshe Laudon; Nava Zisapel; M Souroujon; D Nof; A Shlitner; Paula Herer; Orna Tzischinsky; Peretz Lavie
Sleep disorders and melatonin rhythms in elderly people.
BMJ (Clinical research ed.) 1994;309(6948):167.
1992: J Dymshitz; Moshe Laudon; Nira Ben-Jonathan
Endothelin-induced biphasic response of lactotrophs cultured under different conditions.
Neuroendocrinology 1992;55(6):724-9.
1991: Moshe Laudon; Nava Zisapel
Melatonin binding proteins identified in the rat brain by affinity labeling.
FEBS letters 1991;288(1-2):105-8.
1990: Ora Hirsch Pescovitz; S A Berry; Moshe Laudon; Nira Ben-Jonathan; A Martin-Myers; S M Hsu; T J Lambros; A M Felix
Localization and growth hormone (GH)-releasing activity of rat testicular GH-releasing hormone-like peptide.
Endocrinology 1990;127(5):2336-42.
1990: Moshe Laudon; D A Grossman; Nira Ben-Jonathan
Prolactin-releasing factor: cellular origin in the intermediate lobe of the pituitary.
Endocrinology 1990;126(6):3185-92.
1989: Moshe Laudon; J F Hyde; Nira Ben-Jonathan
Ontogeny of prolactin releasing and inhibiting activities in the posterior pituitary of male rats.
Neuroendocrinology 1989;50(6):644-9.
1988: Moshe Laudon; I Nir; Nava Zisapel
Melatonin receptors in discrete brain areas of the male rat. Impact of aging on density and on circadian rhythmicity.
Neuroendocrinology 1988;48(6):577-83.
1988: Nava Zisapel; I Nir; Moshe Laudon
Circadian variations in melatonin-binding sites in discrete areas of the male rat brain.
FEBS letters 1988;232(1):172-6.
1988: Moshe Laudon; Zvi Yaron; Nava Zisapel
N-(2,4-dinitrophenyl)-5-methoxytryptamine, a novel melatonin antagonist: effects on sexual maturation of the male and female rat and on oestrous cycles of the female rat [corrected].
The Journal of endocrinology 1988;116(1):43-53.
1987: Nava Zisapel; M Shaharabani; Moshe Laudon
Regulation of melatonin's activity in the female rat brain by estradiol: effects on neurotransmitter release and on iodomelatonin binding sites.
Neuroendocrinology 1987;46(3):207-16.
1987: Nava Zisapel; Moshe Laudon
A novel melatonin antagonist affects melatonin-mediated processes in vitro and in vivo.
European journal of pharmacology 1987;136(2):259-60.
1987: Moshe Laudon; Nava Zisapel
Impact of circulating estradiol on melatonin binding sites in discrete areas of the female rat brain.
Brain research 1987;402(1):146-50.
1986: Moshe Laudon; Nava Zisapel
Characterization of central melatonin receptors using 125I-melatonin.
FEBS letters 1986;197(1-2):9-12.
1985: Nava Zisapel; Y Egozi; Moshe Laudon
Circadian variations in the inhibition of dopamine release from adult and newborn rat hypothalamus by melatonin.
Neuroendocrinology 1985;40(2):102-8.
1983: Nava Zisapel; Moshe Laudon
Inhibition by melatonin of dopamine release from rat hypothalamus: regulation of calcium entry.
Brain research 1983;272(2):378-81.
1983: Nava Zisapel; Y Egozi; Moshe Laudon
Inhibition by melatonin of dopamine release from rat hypothalamus in vitro: variations with sex and the estrous cycle.
Neuroendocrinology 1983;37(1):41-7.
1982: Nava Zisapel; R Miskin; Moshe Laudon; H Soreq
Plasminogen activator is enriched in the synaptosomal plasma membranes.
Brain research 1982;248(1):129-39.
1982: Nava Zisapel; Y Egozi; Moshe Laudon
Inhibition of dopamine release by melatonin: regional distribution in the rat brain.
Brain research 1982;246(1):161-3.
1982: Nava Zisapel; Moshe Laudon
Dopamine release induced by electrical field stimulation of rat hypothalamus in vitro: inhibition by melatonin.
Biochemical and biophysical research communications 1982;104(4):1610-6.